Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 Jan;111(1):325–331. doi: 10.1111/j.1476-5381.1994.tb14063.x

Effects of NG-nitro-L-arginine methyl ester on regional haemodynamic responses to MgSO4 in conscious rats.

P A Kemp 1, S M Gardiner 1, J E March 1, T Bennett 1, P C Rubin 1
PMCID: PMC1910029  PMID: 8012714

Abstract

1. We assessed regional haemodynamic responses to the vasodilator, MgSO4, in the absence and presence of the nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME), in conscious chronically instrumented Long Evans rats (n = 9). 2. MgSO4 (loading dose 220 mumol kg-1 min-1 for 7 min, maintenance dose 56 mumol kg-1 min-1 for 7 min), alone, caused slight bradycardia and hypotension accompanied by reductions in renal and mesenteric flows, but a marked hyperaemic vasodilatation in the hindquarters (flow, delta 54 +/- 6%, vascular conductance, delta 77 +/- 5%). 3. L-NAME (183 nmol kg-1 min-1) caused hypertension (29 +/- 2 mmHg) accompanied by bradycardia (-51 +/- 6 beats min-1) and reductions in flow and vascular conductance in the renal (-18 +/- 4% and -35 +/- 3%, respectively), mesenteric (-35 +/- 3% and -49 +/- 3%, respectively), and hindquarters (-26 +/- 3% and -42 +/- 3%, respectively) vascular beds. In the presence of L-NAME, the hypotensive and bradycardic effects of MgSO4 were still apparent, but its hindquarters hyperaemic vasodilator effect was significantly attenuated. 4. In order to determine if the inhibitory action of L-NAME on the hindquarters hyperaemic vasodilator action of MgSO4 was a non-specific effect, due to the change in baseline conditions caused by L-NAME, we also examined responses to MgSO4 in the presence of endothelin-1 (12.5 pmol kg-1 min-1) or angiotensin II (50 pmol kg-1 min-1). In the presence of either peptide, the overall effects of MgSO4 on hindquarters flow and vascular conductance were unchanged.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
325

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altura B. M., Altura B. T. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. II. Experimental aspects. Magnesium. 1985;4(5-6):245–271. [PubMed] [Google Scholar]
  2. Altura B. T., Altura B. M. Endothelium-dependent relaxation in coronary arteries requires magnesium ions. Br J Pharmacol. 1987 Jul;91(3):449–451. doi: 10.1111/j.1476-5381.1987.tb11235.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bilski A. J., Halliday S. E., Fitzgerald J. D., Wale J. L. The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118,551). J Cardiovasc Pharmacol. 1983 May-Jun;5(3):430–437. doi: 10.1097/00005344-198305000-00013. [DOI] [PubMed] [Google Scholar]
  4. Buxton I. L., Cheek D. J., Eckman D., Westfall D. P., Sanders K. M., Keef K. D. NG-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res. 1993 Feb;72(2):387–395. doi: 10.1161/01.res.72.2.387. [DOI] [PubMed] [Google Scholar]
  5. Cocks T. M., Little P. J., Angus J. A., Cragoe E. J., Jr Amiloride analogues cause endothelium-dependent relaxation in the canine coronary artery in vitro: possible role of Na+/Ca2+ exchange. Br J Pharmacol. 1988 Sep;95(1):67–76. doi: 10.1111/j.1476-5381.1988.tb16549.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. D'Angelo E. K., Singer H. A., Rembold C. M. Magnesium relaxes arterial smooth muscle by decreasing intracellular Ca2+ without changing intracellular Mg2+. J Clin Invest. 1992 Jun;89(6):1988–1994. doi: 10.1172/JCI115807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. DiPette D. J., Simpson K., Guntupalli J. Systemic and regional hemodynamic effect of acute magnesium administration in the normotensive and hypertensive state. Magnesium. 1987;6(3):136–149. [PubMed] [Google Scholar]
  8. Gardiner S. M., Bennett T., Compton A. M. Regional haemodynamic effects of neuropeptide Y, vasopressin and angiotensin II in conscious, unrestrained, Long Evans and Brattleboro rats. J Auton Nerv Syst. 1988 Sep;24(1-2):15–27. doi: 10.1016/0165-1838(88)90131-2. [DOI] [PubMed] [Google Scholar]
  9. Gardiner S. M., Bennett T. Involvement of nitric oxide in the regional haemodynamic effects of perindoprilat and captopril in hypovolaemic Brattleboro rats. Br J Pharmacol. 1992 Dec;107(4):1181–1191. doi: 10.1111/j.1476-5381.1992.tb13426.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gardiner S. M., Bennett T. Regional hemodynamic responses to adrenoceptor antagonism in conscious rats. Am J Physiol. 1988 Oct;255(4 Pt 2):H813–H824. doi: 10.1152/ajpheart.1988.255.4.H813. [DOI] [PubMed] [Google Scholar]
  11. Gardiner S. M., Compton A. M., Bennett T., Hartley C. J. Can pulsed Doppler technique measure changes in aortic blood flow in conscious rats? Am J Physiol. 1990 Aug;259(2 Pt 2):H448–H456. doi: 10.1152/ajpheart.1990.259.2.H448. [DOI] [PubMed] [Google Scholar]
  12. Gardiner S. M., Compton A. M., Bennett T. Regional haemodynamic effects of endothelin-1 and endothelin-3 in conscious Long Evans and Brattleboro rats. Br J Pharmacol. 1990 Jan;99(1):107–112. doi: 10.1111/j.1476-5381.1990.tb14662.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gardiner S. M., Compton A. M., Bennett T. Regional haemodynamic effects of human alpha- and beta-calcitonin gene-related peptide in conscious Wistar rats. Br J Pharmacol. 1989 Dec;98(4):1225–1232. doi: 10.1111/j.1476-5381.1989.tb12668.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gardiner S. M., Compton A. M., Bennett T. Regional hemodynamic effects of calcitonin gene-related peptide. Am J Physiol. 1989 Feb;256(2 Pt 2):R332–R338. doi: 10.1152/ajpregu.1989.256.2.R332. [DOI] [PubMed] [Google Scholar]
  15. Gardiner S. M., Compton A. M., Bennett T. Regional hemodynamic effects of endothelin-1 in conscious, unrestrained, Wistar rats. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S202–S204. doi: 10.1097/00005344-198900135-00057. [DOI] [PubMed] [Google Scholar]
  16. Gardiner S. M., Compton A. M., Kemp P. A., Bennett T., Foulkes R., Hughes B. Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats. Br J Pharmacol. 1991 May;103(1):1256–1262. doi: 10.1111/j.1476-5381.1991.tb12333.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gardiner S. M., Compton A. M., Kemp P. A., Bennett T. Regional and cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats. Br J Pharmacol. 1990 Nov;101(3):625–631. doi: 10.1111/j.1476-5381.1990.tb14131.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gardiner S. M., Kemp P. A., Bennett T., Bose C., Foulkes R., Hughes B. Involvement of beta 2-adrenoceptors in the regional haemodynamic responses to bradykinin in conscious rats. Br J Pharmacol. 1992 Apr;105(4):839–848. doi: 10.1111/j.1476-5381.1992.tb09066.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gardiner S. M., Kemp P. A., Bennett T. Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, 5'-N-ethylcarboxamidoadenosine or salbutamol in conscious rats. Br J Pharmacol. 1991 Jul;103(3):1725–1732. doi: 10.1111/j.1476-5381.1991.tb09854.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gardiner S. M., Kemp P. A., Bennett T. Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to adrenaline or BRL 38227 in conscious rats. Br J Pharmacol. 1991 Nov;104(3):731–737. doi: 10.1111/j.1476-5381.1991.tb12496.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Haywood J. R., Shaffer R. A., Fastenow C., Fink G. D., Brody M. J. Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat. Am J Physiol. 1981 Aug;241(2):H273–H278. doi: 10.1152/ajpheart.1981.241.2.H273. [DOI] [PubMed] [Google Scholar]
  22. Horner S. M. Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Meta-analysis of magnesium in acute myocardial infarction. Circulation. 1992 Sep;86(3):774–779. doi: 10.1161/01.cir.86.3.774. [DOI] [PubMed] [Google Scholar]
  23. Kawasaki H., Takasaki K., Saito A., Goto K. Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature. 1988 Sep 8;335(6186):164–167. doi: 10.1038/335164a0. [DOI] [PubMed] [Google Scholar]
  24. Kemp P. A., Gardiner S. M., Bennett T., Rubin P. C. Magnesium sulphate reverses the carotid vasoconstriction caused by endothelin-I, angiotensin II and neuropeptide-Y, but not that caused by NG-nitro-L-arginine methyl ester, in conscious rats. Clin Sci (Lond) 1993 Aug;85(2):175–181. doi: 10.1042/cs0850175. [DOI] [PubMed] [Google Scholar]
  25. Ku D. D., Ann H. S. Differential effects of magnesium on basal and agonist-induced EDRF relaxation in canine coronary arteries. J Cardiovasc Pharmacol. 1991 Jun;17(6):999–1006. doi: 10.1097/00005344-199106000-00021. [DOI] [PubMed] [Google Scholar]
  26. Laurant P., Moussard C., Alber D., Henry J. C., Berthelot A. In vivo and in vitro magnesium effects on aortic prostacyclin generation in DOCA-salt hypertensive rats. Prostaglandins Leukot Essent Fatty Acids. 1992 Nov;47(3):183–186. doi: 10.1016/0952-3278(92)90236-c. [DOI] [PubMed] [Google Scholar]
  27. Marshall I., Al-Kazwini S. J., Holman J. J., Craig R. K. Human and rat alpha-CGRP but not calcitonin cause mesenteric vasodilatation in rats. Eur J Pharmacol. 1986 Apr 16;123(2):217–222. doi: 10.1016/0014-2999(86)90662-x. [DOI] [PubMed] [Google Scholar]
  28. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
  29. Nadler J. L., Goodson S., Rude R. K. Evidence that prostacyclin mediates the vascular action of magnesium in humans. Hypertension. 1987 Apr;9(4):379–383. doi: 10.1161/01.hyp.9.4.379. [DOI] [PubMed] [Google Scholar]
  30. Nakazato Y., Ohga A., Yamada Y. Facilitation of transmitter action on catecholamine output by cardiac glycoside in perfused adrenal gland of guinea-pig. J Physiol. 1986 May;374:475–491. doi: 10.1113/jphysiol.1986.sp016092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Phillips K., Gardiner S. M., Kemp P. A., Bennett T. Factors affecting the regional haemodynamic responses to glyceryl trinitrate and molsidomine in conscious rats. Br J Pharmacol. 1991 Sep;104(1):151–158. doi: 10.1111/j.1476-5381.1991.tb12400.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Steinberg H., Medvedev O. S., Luft F. C., Unger T. Effect of a prostacyclin derivative (iloprost) on regional blood flow, sympathetic nerve activity, and baroreceptor reflex in the conscious rat. J Cardiovasc Pharmacol. 1988 Jan;11(1):84–89. doi: 10.1097/00005344-198801000-00013. [DOI] [PubMed] [Google Scholar]
  33. Teo K. K., Yusuf S., Collins R., Held P. H., Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. BMJ. 1991 Dec 14;303(6816):1499–1503. doi: 10.1136/bmj.303.6816.1499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Theodorsson-Norheim E. Friedman and Quade tests: BASIC computer program to perform nonparametric two-way analysis of variance and multiple comparisons on ranks of several related samples. Comput Biol Med. 1987;17(2):85–99. doi: 10.1016/0010-4825(87)90003-5. [DOI] [PubMed] [Google Scholar]
  35. Woods K. L., Fletcher S., Roffe C., Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) Lancet. 1992 Jun 27;339(8809):1553–1558. doi: 10.1016/0140-6736(92)91828-v. [DOI] [PubMed] [Google Scholar]
  36. Zhang A. M., Altura B. T., Altura B. M. Endothelial-dependent sexual dimorphism in vascular smooth muscle: role of Mg2+ and Na+. Br J Pharmacol. 1992 Feb;105(2):305–310. doi: 10.1111/j.1476-5381.1992.tb14250.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES